Artificial Intelligence Market Analysis By Solution, Technology, End-use & Region, 2014 - 2025
DUBLIN - August 18, 2017 (Investorideas.com Newswire) The "Artificial Intelligence Market Analysis By Solution (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Natural Language Processing, Machine Vision), By End-use, By Region, and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.
The global artificial intelligence market is expected to reach USD 35,870.0 million by 2025 from its direct revenue sources, growing at a CAGR of 57.2% from 2017 to 2025, whereas it is expected to garner around USD 58,975.4 million by 2025 from its enabled revenue arenas, according to this new report.
The North American region is expected to dominate the industry due to the availability of high government funding, the presence of leading players, and strong technical base. Advances in image and voice recognition are driving the growth of the artificial intelligence market as improved image recognition technology is critical to offer enhanced drones, self-driving cars, and robotics. The AI market can be categorized based on solutions, technologies, end use, and geography.
The two major factors enabling market growth are emerging AI technologies and growth in big data espousal. The growing prominence of artificial intelligence is enabling new players to venture into the market by offering niche application-specific solutions. Furthermore, companies are also engaging in industry consolidations in a bid to gain competitive advantages.
The Asia Pacific regional market is expected to be the fastest-growing market, owing to the rapid improvements in information storage capacity, high computing power, and parallel processing, which have contributed to the swift uptake of artificial intelligence technology in end-use industries such as automotive and healthcare.
AI has the potential to reduce the burden on clinicians and provide an efficient tool to workforces for accomplishing their tasks in a better way. For instance, AI voice-enabled symptom checkers can better access a situation and assist patients to the emergency department when immediate treatment is required. AI is expected to resolve around 20% of unmet healthcare demands.
Key Topics Covered:
1 Methodology and Scope
2. Executive Summary
3. Artificial Intelligence Market Variables, Trends, and Scope
4. Artificial Intelligence Market: Solution Estimates & Trend Analysis
5. Artificial Intelligence Market: Technology Estimates & Trend Analysis
6. Artificial Intelligence Market: End Use Estimates & Trend Analysis
7. Artificial Intelligence Market: Regional Estimates & Trend Analysis
8. Competitive Landscape
- Atomwise, Inc.
- Sense.ly, Inc.
- Zebra Medical Vision, Inc.
- Baidu, Inc.
- Cyrcadia Health
- IBM Watson Health
- IRIS AI
- NVIDIA Corporation
- Advanced Micro Devices, Inc.
- ARM Ltd.
- Clarifai, Inc.
- Enlitic, Inc.
- Google, Inc.
- HyperVerge, Inc.
- IBM Corporation
- Intel Corporation
- Microsoft Corporation
For more information about this report visit https://www.researchandmarkets.com/research/fflh8w/artificial
Research and Markets
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Artificial Intelligence
TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)
Like Tech Stocks? View our Tech Stocks Directory
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.